The occurrence of immune-related adverse events indicates better efficacy of immune checkpoint blockade in solid tumors: A systematic review and meta-analysis

被引：0
|
作者：
Yang, Xu
Wang, Dongxu
Lin, Jianzhen
Xiong, Jianping
Long, Junyu
Bai, Yi
Bian, Jin
Huang, Hanchun
Yang, Xiaobo
Mao, Yilei
Sang, Xinting
Zhao, Haitao
机构：
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China
[2] Peking Union Med, Beijing, Peoples R China
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-4992
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4992
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis
    Hao, Wenjing
    Zhang, Jun
    Wang, Yunxia
    Fang, Boyu
    Jin, Shasha
    Yuan, Jing
    Cai, Weimin
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [42] Immune-related adverse events of immune checkpoint inhibitors: a brief review
    Myers, G.
    CURRENT ONCOLOGY, 2018, 25 (05) : 342 - 347
  • [43] Analysis and evaluation of factors contributing to the occurrence of immune-related adverse events with immune checkpoint inhibitors
    Nagase, T.
    Shima, O.
    Maruhana, N.
    Miyazawa, Y.
    Yoshino, S.
    Sato, J.
    Yamada, H.
    Shinozaki, K.
    Ikeda, K.
    PHARMAZIE, 2024, 79 (7-8): : 163 - 168
  • [44] Predictive value of NLR and PLR for immune-related adverse events: a systematic review and meta-analysis
    Hong-Rui Lu
    Peng-Fei Zhu
    Ya-Ya Deng
    Zhe-Ling Chen
    Liu Yang
    Clinical and Translational Oncology, 2024, 26 : 1106 - 1116
  • [45] Predictive value of NLR and PLR for immune-related adverse events: a systematic review and meta-analysis
    Lu, Hong-Rui
    Zhu, Peng-Fei
    Deng, Ya-Ya
    Chen, Zhe-Ling
    Yang, Liu
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (05): : 1106 - 1116
  • [46] Sarcopenia as biomarker for immunotherapy outcomes and immune-related adverse events - a systematic review and meta-analysis
    Guenther, S.
    Trinkner, P.
    von Bergwelt, M.
    dos Santos, Cordas D.
    Theurich, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 228 - 228
  • [47] SARCOPENIA AS BIOMARKER FOR IMMUNOTHERAPY OUTCOMES AND IMMUNE-RELATED ADVERSE EVENTS - A SYSTEMATIC REVIEW AND META-ANALYSIS
    Guenther, S.
    Trinkner, P.
    von Bergwelt, M.
    dos Santos, D. Cordas
    Theurich, S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A7 - A7
  • [48] The correlation between immune-related adverse events and efficacy of immune checkpoint inhibitors
    Fukushima, Taito
    Kobayashi, Satoshi
    Ueno, Makoto
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (09) : 949 - 958
  • [49] Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors
    Zhong, Li
    Wu, Qing
    Chen, Fuchun
    Liu, Junjin
    Xie, Xianhe
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2559 - 2576
  • [50] Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors
    Li Zhong
    Qing Wu
    Fuchun Chen
    Junjin Liu
    Xianhe Xie
    Cancer Immunology, Immunotherapy, 2021, 70 : 2559 - 2576
12345